BruceWelshBodeMD

Endocrinology • Atlanta, GA

Endocrinologist at Atlanta Diabetes Associates

Join to view full profile

Dr. Bode is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bode's full profile

Already have an account?

Office
1800 Howell Mill Rd NW
Ste 450
Atlanta, GA 30318
Phone+1 404-355-4393

Fax+1 404-609-7665

Education & Training

Emory University School of MedicineResidency, Internal Medicine, 1981 - 1984
Emory University School of MedicineClass of 1981

Certifications & Licensure

GA State Medical License 1982 - 2025
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Top MD Consumers Checkbook
Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU Start of enrollment: 2006 Jun 01
Completed
Not Applicable
A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection Port Start of enrollment: 2006 Oct 01
Completed
Not Applicable
Glucose Meter Study Start of enrollment: 2008 Nov 01
Completed
Not Applicable
Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes Start of enrollment: 2008 Feb 01
Completed
Not Applicable
A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II Start of enrollment: 2010 Oct 01
Withdrawn
Phase 2
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus Start of enrollment: 2012 May 01
Completed
Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277® Start of enrollment: 2013 Oct 01
Terminated
Phase 3
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Completed
Not Applicable
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System Start of enrollment: 2014 Feb 01
Completed
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus Start of enrollment: 2014 Mar 01
Terminated
Phase 2
In Clinic Evaluation of the PLGM Feature Start of enrollment: 2014 Oct 01
Completed
Not Applicable
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes Start of enrollment: 2015 Jun 01
Completed
Not Applicable
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
T1 Diabetes Hypoglycemia Prevention Pilot Start of enrollment: 2016 May 01
Terminated
Not Applicable
A Study of LY3209590 in Participants With Type 1 Diabetes Start of enrollment: 2020 Jul 06
Completed
Phase 2
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes Start of enrollment: 2020 Oct 30
Completed
Phase 2
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range) Start of enrollment: 2020 Nov 04
Completed
Phase 3
Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes Start of enrollment: 2020 Nov 23
Completed
Not Applicable
A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes Start of enrollment: 2020 Sep 15
Completed
Early Phase 1
Use of the Guardian™ Connect System With Smart Connected Devices Start of enrollment: 2021 Apr 06
Completed
Not Applicable
Evaluation of Medtronic DUO Extended Set Start of enrollment: 2021 Mar 18
Recruiting
Not Applicable
Eversense® Non-adjunctive Use Post Approval Study Start of enrollment: 2021 Apr 13
Recruiting
Not Applicable
Roles: Principal Investigator
A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function Start of enrollment: 2020 Dec 21
Active, not recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

407 citations
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
Richard M. Bergenstal, Satish K. Garg, Stuart A. Weinzimer, Bruce A. Buckingham, Bruce W. Bode
JAMA. 2016-10-04
158 citations
New Insulin Delivery Recommendations
Anders Frid, G Kreugel, Giorgio Grassi, Serge Halimi, D Hicks
Mayo Clinic Proceedings. 2016-09-01
164 citations
Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study.
Bruce W. Bode, Todd M. Gross, Kay R. Thornton, John J. Mastrototaro
Diabetes Research and Clinical Practice. 1999-12-01

Press Mentions

Glytec’s Glucommander Software Combined with Continuous Glucose Monitoring Enables Patients with Diabetes to Improve Time in Range by More Than 25% in Only Four WeeksJune 15th, 2020
Bruce Bode, MD: Hypoglycemic Effect of Hepatic-Directed InsulinJune 17th, 2019
Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic RetinopathyJune 5th, 2019
Join now to see all

BruceWelshBodeMD

Dr. Bode is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.